Bromodomains: A novel target for the anticancer therapy-Reference-Cited by-同舟云学术

Bromodomains: A novel target for the anticancer therapy

Published:2021-11 Issue: Volume:911 Page:174523
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Gokani Shivani,Bhatt Lokesh Kumar^ORCID

Publisher

Elsevier BV

Subject

Pharmacology

Reference84 articles.

1. Identification of a benzoisoxazoloazepine inhibitor (CPI-0610) of the bromodomain and extra-terminal (BET) family as a candidate for human clinical trials;Albrecht;J. Med. Chem.,2016

2. The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains;Alekseyenko;Genes Dev.,2015

3. Bromodomain-containing protein 4: a dynamic regulator of breast cancer metastasis through modulation of the extracellular matrix;Alsarraj;Int. J. Breast Cancer,2012

4. BET bromodomains mediate transcriptional pause release in heart failure;Anand;Cell,2013

5. BET inhibitors induce apoptosis through a MYC independent mechanism and synergise with CDK inhibitors to kill osteosarcoma cells;Baker;Sci. Rep.,2015

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Candidate molecular targets uncovered in mouse lifespan extension studies;Expert Opinion on Therapeutic Targets;2024-04-30

2. Degraders in epigenetic therapy: PROTACs and beyond;Theranostics;2024

3. Bromodomain‐containing protein 4 inhibition improves the efficacy of cisplatin and radiotherapy in oral squamous cell carcinoma by suppressing programmed cell death‐ligand 1 expression;Basic & Clinical Pharmacology & Toxicology;2023-12-06

4. New Flavone Derivatives Targeting BET Proteins in Cancer: Synthesis, Structure Analysis and Investigation of Bromodomain Inhibitory Activities**;ChemistrySelect;2023-11-02

5. BRD2 protects the rat H9C2 cardiomyocytes from hypoxia‑reoxygenation injury by targeting Nrf2/HO‑1 signaling pathway;Experimental and Therapeutic Medicine;2023-10-04